Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta‐analysis

@article{Iftikhar2017GabapentinEP,
  title={Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta‐analysis},
  author={Imran H. Iftikhar and Lana Alghothani and Lynn Marie Trotti},
  journal={European Journal of Neurology},
  year={2017},
  volume={24}
}
To synthesize evidence from available randomized controlled trials (RCT) to compare the efficacies of dopaminergic drugs (pramipexole, ropinirole and rotigotine) and α‐2‐δ ligands (gabapentin enacarbil and pregabalin) for the treatment of restless legs syndrome (RLS). We searched PubMed for all eligible RCTs. Network meta‐analysis using frequentist methodology with random effect models was performed for mean changes in scores on the International RLS Study Group Rating Scale (IRLS) and for… Expand
Quantitative Comparison of the Efficacies of 5 First‐Line Drugs for Primary Restless Leg Syndrome
TLDR
In RLS patients with more severe symptoms, the therapeutic effect of dopaminergic agonists tended to be better than that of α‐2‐δ ligands and this effect was found to be associated with baseline symptom severity. Expand
The Efficacy and Safety of Pharmacological Treatments for Restless Legs Syndrome: Systemic Review and Network Meta-Analysis
  • Xuan Zhou, Juncong Du, +6 authors Lifen Chen
  • Medicine
  • Frontiers in Neuroscience
  • 2021
TLDR
The pooled results showed that, compared with placebo, only levodopa is inefficient to relieve symptoms of RLS, and Alpha-2-delta ligands and DAs are favorable choices for both primary and secondary RLS because of their significant efficacy and good tolerability. Expand
Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial.
TLDR
The present pattern of results suggests that glutamatergic medications such as gabapentin and memantine adjuvant to a standard treatment with an SSRI have no additional positive impact on patients with OCD, as measured with the Y-BOCS. Expand
The efficacy of gabapentin in reducing pain intensity and morphine consumption after breast cancer surgery
TLDR
Preoperative use of gabapentin was able to reduce acute and chronic postoperative pain, total morphine consumption and the occurrence of nausea following breast cancer surgery. Expand
Therapies for Restless Legs in Parkinson’s Disease
TLDR
The aim of this article was to review the options and particularities of the treatment of restless legs syndrome (RLS) in Parkinson’s disease (PD), finding that arrangements linked to the peculiar population and pathology of PD are required. Expand
Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis
TLDR
All drugs except for tralokinumab showed improvements in FEV1, ACQ, and AQLQ and only reslizumab and dupilumab were associated with statistically significant reductions in asthma exacerbation rates. Expand
Acupuncture for restless legs syndrome
TLDR
A comprehensive systematic review and meta-analysis will evaluate the evidence of randomized controlled trials for acupuncture treatment of Restless legs syndrome to explore whether acupuncture is an effective and safe intervention for RLS. Expand
Therapies for Restless Legs in Parkinson's Disease.
TLDR
The treatment of RLS in PD consists in adaptation of dopaminergic treatment and introduction of alpha-2-delta ligands and, in refractory cases, of opioids or deep brain stimulation. Expand
The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials
TLDR
Among antiepileptics and antidepressants, duloxetine appeared to have the most detailed safety for the treatment of peripheral neuropathic pain, and over all studies, the most commonly reported adverse effects were dizziness, drowsiness, nausea, and constipation. Expand
Effectiveness and safety of traditional Chinese medicine Shaoyao Gancao Tang for the treatment of restless leg syndrome
TLDR
A high-quality synthesis of current evidence of Shaoyao Gancao Tang's effectiveness and safety for patients with RLS will be provided. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 32 REFERENCES
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double‐blind, placebo‐controlled pilot study
TLDR
This pilot study suggests that continuous delivery of rotigotine by means of a patch may provide an effective and well‐tolerated treatment of RLS symptoms both during night and day. Expand
Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study
TLDR
GEn is effective and well-tolerated for the treatment of RLS in Japanese patients and 600 mg GEn is a suitable target dose; there was a tendency toward a dose-dependent increase in the incidence of adverse events. Expand
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
TLDR
Gabapentin enacarbil at 1200 mg significantly improved restless legs syndrome symptoms compared with placebo and Investigator-rated Clinical Global Impression-Improvement scale responses also significantly favored GEn at 1200mg compared with Placebo. Expand
Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study.
TLDR
It was shown that PPX is efficacious and well tolerated in Chinese people with primary RLS and the CGI-I rating of "very much improved" or "much improved" in the percentage of participants was very much improved. Expand
Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome
TLDR
Gabapentin enacarbil 1200 mg once daily significantly reduces restless legs syndrome–associated sleep disturbance and periodic limb movements associated with arousal per hour of sleep and is generally well tolerated in adults with moderate to severe primary restless legs Syndrome. Expand
Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
TLDR
This study demonstrated improvements in objective and subjective measures of sleep maintenance and sleep architecture with pregabalin compared with placebo and pramipexole. Expand
Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
TLDR
Pramipexole was effective and well-tolerated in Chinese patients with restless legs syndrome and showed significant improvement compared with the placebo group in the change of their International Restless Legs Syndrome Study Group Rating Scale of Severity (IRLS) total score from baseline to week 6. Expand
Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
TLDR
Pramipexole is effective and safe in the treatment of both objective and subjective facets of RLS and did not produce somnolence at any dose. Expand
A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.
TLDR
XP13512 1800 mg/day significantly reduced RLS symptoms, improved sleep, and was generally well tolerated in subjects with moderate-to-severe primary RLS across 14 days of treatment. Expand
A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
TLDR
Pramipexole is effective and well tolerated in RLS, most notably among objective measures, for reducing PLM and decreasing sleep latency, and patients' subjective ratings of RLS severity and sleep disturbance were significantly improved. Expand
...
1
2
3
4
...